Skip to content

Clinical trials

Phase 2 Inflammation trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20111
20122
20131
20141
20151
20191
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
AstraZeneca2
Abcentra1
Debiopharm International SA1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
Fondazione IRCCS San Gerardo dei Tintori1
GlaxoSmithKline1
Hoffmann-La Roche1
Mario Negri Institute for Pharmacological Research1
University Hospital of Ferrara1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation14
Arthritis, Rheumatoid3
Crohn Disease2
Fibrosis2
Acute Coronary Syndrome1
Acute Pain1
Ascites1
Coronary Artery Disease1
Fractures, Bone1
Heart Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.